IBDEI1VD ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32895,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,32896,0)
 ;;=Z86.72^^182^1993^99
 ;;^UTILITY(U,$J,358.3,32896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32896,1,3,0)
 ;;=3^Personal Hx of Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,32896,1,4,0)
 ;;=4^Z86.72
 ;;^UTILITY(U,$J,358.3,32896,2)
 ;;=^5063476
 ;;^UTILITY(U,$J,358.3,32897,0)
 ;;=Z87.310^^182^1993^92
 ;;^UTILITY(U,$J,358.3,32897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32897,1,3,0)
 ;;=3^Personal Hx of Osteoporosis Fx
 ;;^UTILITY(U,$J,358.3,32897,1,4,0)
 ;;=4^Z87.310
 ;;^UTILITY(U,$J,358.3,32897,2)
 ;;=^5063485
 ;;^UTILITY(U,$J,358.3,32898,0)
 ;;=Z87.442^^182^1993^103
 ;;^UTILITY(U,$J,358.3,32898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32898,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,32898,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,32898,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,32899,0)
 ;;=Z87.81^^182^1993^101
 ;;^UTILITY(U,$J,358.3,32899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32899,1,3,0)
 ;;=3^Personal Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,32899,1,4,0)
 ;;=4^Z87.81
 ;;^UTILITY(U,$J,358.3,32899,2)
 ;;=^5063513
 ;;^UTILITY(U,$J,358.3,32900,0)
 ;;=Z87.890^^182^1993^96
 ;;^UTILITY(U,$J,358.3,32900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32900,1,3,0)
 ;;=3^Personal Hx of Sex Reassignment
 ;;^UTILITY(U,$J,358.3,32900,1,4,0)
 ;;=4^Z87.890
 ;;^UTILITY(U,$J,358.3,32900,2)
 ;;=^5063517
 ;;^UTILITY(U,$J,358.3,32901,0)
 ;;=Z87.892^^182^1993^59
 ;;^UTILITY(U,$J,358.3,32901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32901,1,3,0)
 ;;=3^Personal Hx of Anaphylaxis
 ;;^UTILITY(U,$J,358.3,32901,1,4,0)
 ;;=4^Z87.892
 ;;^UTILITY(U,$J,358.3,32901,2)
 ;;=^5063519
 ;;^UTILITY(U,$J,358.3,32902,0)
 ;;=Z87.39^^182^1993^89
 ;;^UTILITY(U,$J,358.3,32902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32902,1,3,0)
 ;;=3^Personal Hx of Musculoskeletal/Connective Tissue Disease
 ;;^UTILITY(U,$J,358.3,32902,1,4,0)
 ;;=4^Z87.39
 ;;^UTILITY(U,$J,358.3,32902,2)
 ;;=^5063488
 ;;^UTILITY(U,$J,358.3,32903,0)
 ;;=Z87.820^^182^1993^97
 ;;^UTILITY(U,$J,358.3,32903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32903,1,3,0)
 ;;=3^Personal Hx of TBI
 ;;^UTILITY(U,$J,358.3,32903,1,4,0)
 ;;=4^Z87.820
 ;;^UTILITY(U,$J,358.3,32903,2)
 ;;=^5063514
 ;;^UTILITY(U,$J,358.3,32904,0)
 ;;=Z89.511^^182^1993^5
 ;;^UTILITY(U,$J,358.3,32904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32904,1,3,0)
 ;;=3^Acquired Absence of Right Leg Below Knee
 ;;^UTILITY(U,$J,358.3,32904,1,4,0)
 ;;=4^Z89.511
 ;;^UTILITY(U,$J,358.3,32904,2)
 ;;=^5063566
 ;;^UTILITY(U,$J,358.3,32905,0)
 ;;=Z91.82^^182^1993^87
 ;;^UTILITY(U,$J,358.3,32905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32905,1,3,0)
 ;;=3^Personal Hx of Military Deployment
 ;;^UTILITY(U,$J,358.3,32905,1,4,0)
 ;;=4^Z91.82
 ;;^UTILITY(U,$J,358.3,32905,2)
 ;;=^5063626
 ;;^UTILITY(U,$J,358.3,32906,0)
 ;;=Z91.5^^182^1993^95
 ;;^UTILITY(U,$J,358.3,32906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32906,1,3,0)
 ;;=3^Personal Hx of Self-Harm
 ;;^UTILITY(U,$J,358.3,32906,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,32906,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,32907,0)
 ;;=Z89.512^^182^1993^3
 ;;^UTILITY(U,$J,358.3,32907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32907,1,3,0)
 ;;=3^Acquired Absence of Left Leg Below Knee
 ;;^UTILITY(U,$J,358.3,32907,1,4,0)
 ;;=4^Z89.512
 ;;^UTILITY(U,$J,358.3,32907,2)
 ;;=^5063567
 ;;^UTILITY(U,$J,358.3,32908,0)
 ;;=Z89.611^^182^1993^4
 ;;^UTILITY(U,$J,358.3,32908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32908,1,3,0)
 ;;=3^Acquired Absence of Right Leg Above Knee
 ;;
 ;;$END ROU IBDEI1VD
